232 related articles for article (PubMed ID: 26679995)
1. HIV-1 Vpr Protein Induces Proteasomal Degradation of Chromatin-associated Class I HDACs to Overcome Latent Infection of Macrophages.
Romani B; Baygloo NS; Hamidi-Fard M; Aghasadeghi MR; Allahbakhshi E
J Biol Chem; 2016 Feb; 291(6):2696-711. PubMed ID: 26679995
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 Vpr reactivates latent HIV-1 provirus by inducing depletion of class I HDACs on chromatin.
Romani B; Kamali Jamil R; Hamidi-Fard M; Rahimi P; Momen SB; Aghasadeghi MR; Allahbakhshi E
Sci Rep; 2016 Aug; 6():31924. PubMed ID: 27550312
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 Vpr Protein Enhances Proteasomal Degradation of MCM10 DNA Replication Factor through the Cul4-DDB1[VprBP] E3 Ubiquitin Ligase to Induce G2/M Cell Cycle Arrest.
Romani B; Shaykh Baygloo N; Aghasadeghi MR; Allahbakhshi E
J Biol Chem; 2015 Jul; 290(28):17380-9. PubMed ID: 26032416
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 Vpr mediates the depletion of the cellular repressor CTIP2 to counteract viral gene silencing.
Forouzanfar F; Ali S; Wallet C; De Rovere M; Ducloy C; El Mekdad H; El Maassarani M; Aït-Ammar A; Van Assche J; Boutant E; Daouad F; Margottin-Goguet F; Moog C; Van Lint C; Schwartz C; Rohr O
Sci Rep; 2019 Sep; 9(1):13154. PubMed ID: 31511615
[TBL] [Abstract][Full Text] [Related]
5. Identification of SNF2h, a chromatin-remodeling factor, as a novel binding protein of Vpr of human immunodeficiency virus type 1.
Taneichi D; Iijima K; Doi A; Koyama T; Minemoto Y; Tokunaga K; Shimura M; Kano S; Ishizaka Y
J Neuroimmune Pharmacol; 2011 Jun; 6(2):177-87. PubMed ID: 21519849
[TBL] [Abstract][Full Text] [Related]
6. NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation.
Williams SA; Chen LF; Kwon H; Ruiz-Jarabo CM; Verdin E; Greene WC
EMBO J; 2006 Jan; 25(1):139-49. PubMed ID: 16319923
[TBL] [Abstract][Full Text] [Related]
7. Expression of latent human immunodeficiency type 1 is induced by novel and selective histone deacetylase inhibitors.
Archin NM; Keedy KS; Espeseth A; Dang H; Hazuda DJ; Margolis DM
AIDS; 2009 Sep; 23(14):1799-806. PubMed ID: 19590405
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 Vpr induces the degradation of ZIP and sZIP, adaptors of the NuRD chromatin remodeling complex, by hijacking DCAF1/VprBP.
Maudet C; Sourisce A; Dragin L; Lahouassa H; Rain JC; Bouaziz S; Ramirez BC; Margottin-Goguet F
PLoS One; 2013; 8(10):e77320. PubMed ID: 24116224
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 Vpr loads uracil DNA glycosylase-2 onto DCAF1, a substrate recognition subunit of a cullin 4A-ring E3 ubiquitin ligase for proteasome-dependent degradation.
Ahn J; Vu T; Novince Z; Guerrero-Santoro J; Rapic-Otrin V; Gronenborn AM
J Biol Chem; 2010 Nov; 285(48):37333-41. PubMed ID: 20870715
[TBL] [Abstract][Full Text] [Related]
10. Class 1-Selective Histone Deacetylase (HDAC) Inhibitors Enhance HIV Latency Reversal while Preserving the Activity of HDAC Isoforms Necessary for Maximal HIV Gene Expression.
Zaikos TD; Painter MM; Sebastian Kettinger NT; Terry VH; Collins KL
J Virol; 2018 Mar; 92(6):. PubMed ID: 29298886
[TBL] [Abstract][Full Text] [Related]
11. Formation of mobile chromatin-associated nuclear foci containing HIV-1 Vpr and VPRBP is critical for the induction of G2 cell cycle arrest.
Belzile JP; Abrahamyan LG; Gérard FC; Rougeau N; Cohen EA
PLoS Pathog; 2010 Sep; 6(9):e1001080. PubMed ID: 20824083
[TBL] [Abstract][Full Text] [Related]
12. The HIV-1 accessory protein Vpr induces the degradation of the anti-HIV-1 agent APOBEC3G through a VprBP-mediated proteasomal pathway.
Zhou D; Wang Y; Tokunaga K; Huang F; Sun B; Yang R
Virus Res; 2015 Jan; 195():25-34. PubMed ID: 25200749
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 Vpr protein inhibits telomerase activity via the EDD-DDB1-VPRBP E3 ligase complex.
Wang X; Singh S; Jung HY; Yang G; Jun S; Sastry KJ; Park JI
J Biol Chem; 2013 May; 288(22):15474-80. PubMed ID: 23612978
[TBL] [Abstract][Full Text] [Related]
14. The HIV-1 protein Vpr targets the endoribonuclease Dicer for proteasomal degradation to boost macrophage infection.
Casey Klockow L; Sharifi HJ; Wen X; Flagg M; Furuya AK; Nekorchuk M; de Noronha CM
Virology; 2013 Sep; 444(1-2):191-202. PubMed ID: 23849790
[TBL] [Abstract][Full Text] [Related]
15. ZBTB2 represses HIV-1 transcription and is regulated by HIV-1 Vpr and cellular DNA damage responses.
Bruce JW; Bracken M; Evans E; Sherer N; Ahlquist P
PLoS Pathog; 2021 Feb; 17(2):e1009364. PubMed ID: 33635925
[TBL] [Abstract][Full Text] [Related]
16. Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.
Barbosa JAF; Sparapani S; Boulais J; Lodge R; Cohen ÉA
J Virol; 2021 Jul; 95(15):e0097120. PubMed ID: 34011540
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 Vpr hijacks EDD-DYRK2-DDB1
Hossain D; Ferreira Barbosa JA; Cohen ÉA; Tsang WY
J Biol Chem; 2018 Jun; 293(24):9448-9460. PubMed ID: 29724823
[TBL] [Abstract][Full Text] [Related]
18. Vpr Targets TET2 for Degradation by CRL4
Lv L; Wang Q; Xu Y; Tsao LC; Nakagawa T; Guo H; Su L; Xiong Y
Mol Cell; 2018 Jun; 70(5):961-970.e5. PubMed ID: 29883611
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 Accessory Protein Vpr Interacts with REAF/RPRD2 To Mitigate Its Antiviral Activity.
Gibbons JM; Marno KM; Pike R; Lee WJ; Jones CE; Ogunkolade BW; Pardieu C; Bryan A; Fu RM; Warnes G; Rowley PA; Sloan RD; McKnight Á
J Virol; 2020 Jan; 94(4):. PubMed ID: 31776272
[TBL] [Abstract][Full Text] [Related]
20. Inhibitors of histone deacetylases: correlation between isoform specificity and reactivation of HIV type 1 (HIV-1) from latently infected cells.
Huber K; Doyon G; Plaks J; Fyne E; Mellors JW; Sluis-Cremer N
J Biol Chem; 2011 Jun; 286(25):22211-8. PubMed ID: 21531716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
